Literature DB >> 23451329

Fine needle aspiration biopsy of malignant mass lesions in the liver: a revisit of diagnostic profiles and challenges.

Aileen Wee1.   

Abstract

Year:  2013        PMID： 23451329      PMCID： PMC3562630          DOI： 10.3978/j.issn.2078-6891.2012.064

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN： 2078-6891


× No keyword cloud information.
  21 in total

1.  Diagnosis of hepatocellular carcinoma: fine needle aspiration cytology or needle core biopsy.

Authors:  Dhanpat Jain
Journal:  J Clin Gastroenterol       Date:  2002 Nov-Dec       Impact factor: 3.062

2.  Fine needle aspiration cytology in the diagnosis of liver lesions.

Authors:  Wei Ding; Xiao-Jun He
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-02

3.  EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2012-04       Impact factor: 25.083

4.  Fine-needle aspiration biopsy of hepatic lesions: computerized tomographic-guided versus endoscopic ultrasound-guided FNA.

Authors:  D Ralph Crowe; Mohamad A Eloubeidi; David C Chhieng; Nirag C Jhala; Darshana Jhala; Isam A Eltoum
Journal:  Cancer       Date:  2006-06-25       Impact factor: 6.860

5.  The value of fine needle aspiration biopsy in the diagnosis of metastatic liver tumours.

Authors:  Işin Soyuer; Cemil Ekinci; Muhsin Kaya; Kadir Bahar
Journal:  Turk J Gastroenterol       Date:  2002-06       Impact factor: 1.852

6.  Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics.

Authors:  Aileen Wee
Journal:  Appl Immunohistochem Mol Morphol       Date:  2006-09

7.  Agreement between rapid onsite and final cytologic interpretations of EUS-guided FNA specimens: implications for the endosonographer and patient management.

Authors:  Mohamad A Eloubeidi; Ashutosh Tamhane; Nirag Jhala; David Chhieng; Darshana Jhala; D Ralph Crowe; Isam A Eltoum
Journal:  Am J Gastroenterol       Date:  2006-10-06       Impact factor: 10.864

8.  HepPar1, MOC-31, pCEA, mCEA and CD10 for distinguishing hepatocellular carcinoma vs. metastatic adenocarcinoma in liver fine needle aspirates.

Authors:  Luoquan Wang; Magalis Vuolo; Mark J Suhrland; Kathie Schlesinger
Journal:  Acta Cytol       Date:  2006 May-Jun       Impact factor: 2.319

9.  Recent immunohistochemical markers in the differential diagnosis of primary and metastatic carcinomas of the liver.

Authors:  Murat Gokden; Anjali Shinde
Journal:  Diagn Cytopathol       Date:  2005-09       Impact factor: 1.582

10.  Comparison of liver biopsy and noninvasive methods for diagnosis of hepatocellular carcinoma.

Authors:  Eldad S Bialecki; Amobi M Ezenekwe; Elizabeth M Brunt; Brian T Collins; T Brent Ponder; B Kirke Bieneman; Adrian M Di Bisceglie
Journal:  Clin Gastroenterol Hepatol       Date:  2006-03       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.